Fematroz Tablet
Fematroz Tablet

Fematroz Tablet

MOQ : 100 Boxes

Fematroz Tablet Specification

  • Salt Composition
  • Letrozole 2.5 mg
  • Indication
  • Breast Cancer (Hormone receptor-positive) in postmenopausal women
  • Dosage Form
  • Tablet
  • Enzyme Types
  • Aromatase Inhibitor
  • Feature
  • Effective oral non-steroidal aromatase inhibitor
  • Ingredients
  • Letrozole, Excipients
  • Application
  • Hormone therapy for cancer
  • Physical Color/Texture
  • Yellow, round, film-coated tablets
  • Fermentation Smell
  • Odorless
  • Enzymatic Activity
  • Inhibits aromatase enzyme activity
  • Storage Instructions
  • Store below 25C, protect from moisture and light
  • Shelf Life
  • 24-36 months
  • Usage Age Group
  • Adults
  • Route of Administration
  • Oral
  • Brand Name
  • Fematroz
  • Regulatory Status
  • Approved by regulatory authorities for medical use
  • Tablet Imprint
  • Sometimes debossed with 'Letroz 2.5' or similar
  • Pack Size
  • 10 tablets per strip
  • ATC Classification
  • L02BG04
  • Prescription Status
  • Prescription Only
  • Patient Instructions
  • Take as directed by physician, do not exceed recommended dose
  • Warning
  • Not for use in premenopausal women or during pregnancy
 

Fematroz Tablet Trade Information

  • Minimum Order Quantity
  • 100 Boxes
  • Payment Terms
  • Cash in Advance (CID)
  • Supply Ability
  • 5000 Boxes Per Month
  • Delivery Time
  • 2-10 Days
  • Main Domestic Market
  • All India
 

About Fematroz Tablet



Fematroz Tablet, a select formulation containing 2.5 mg Letrozole, stands out as a first-class, prescription-only therapy notably utilised for hormone receptor-positive breast cancer in postmenopausal women. Scarce yet powerful, this non-steroidal aromatase inhibitor is noteworthy for its clinical precision-effectively impeding enzymatic activity central to tumor growth. Patients benefit from its oral administration and soaring efficacy, backed by regulatory approvals. Take as directed by your physician, and be sure not to exceed recommended doses. Offer yourself trusted support with Fematroz, stored below 25C for optimal potency.

Advantage and Surface of Application

Fematroz Tablet brings a remarkable advantage in advancing hormone therapy for breast cancer, especially in adult postmenopausal women. Its smooth, yellow, round film-coated surface is easy to ingest, ensuring comfortable oral administration. Utilised specifically for hormone receptor-positive breast cancer, Fematroz targets aromatase enzymes, supporting treatment with superior effectiveness while maintaining patient compliance and convenience. This scoring advance makes Fematroz a preferred choice where clinical performance is paramount.


Certifications, Export Policy, and Market Reach

Fematroz, shipped from trusted suppliers in India, carries certification by relevant regulatory authorities guaranteeing first-class quality. Possessing an extensive shelf life of 24-36 months, these tablets meet both domestic and export market demands, with samples available upon select requests. Dispatched securely to maintain integrity and freshness, Fematroz is noteworthy for its growing presence across regions. The main domestic market is India, but its reliable shipment and compliance procedures facilitate confident global distribution.


FAQ's of Fematroz Tablet:


Q: How should Fematroz Tablet be administered for optimal results?

A: Fematroz Tablet should be taken orally exactly as prescribed by your physician. Do not exceed the recommended dose, and take each tablet with water, maintaining a consistent daily schedule.

Q: What is the main indication for using Fematroz Tablet?

A: Fematroz Tablet is indicated for hormone receptor-positive breast cancer treatment in postmenopausal women, making it a select option for this specific patient group.

Q: When should Fematroz not be used?

A: Fematroz should not be used by premenopausal women or during pregnancy, as it is specifically formulated for postmenopausal individuals and may harm other groups.

Q: Where must Fematroz Tablets be stored to retain effectiveness?

A: Store Fematroz Tablets below 25C, protected from moisture and light, to maintain potency and prolong shelf life.

Q: What benefits does Fematroz offer over other oral therapies?

A: Fematroz provides a first-class, non-steroidal aromatase inhibition, leading to noteworthy effectiveness for hormone therapy in managing breast cancer, with a well-tolerated oral dosage form.

Tell us about your requirement
product

Price:

Quantity
Select Unit

  • 50
  • 100
  • 200
  • 250
  • 500
  • 1000+
Additional detail
Mobile number

Email

More Products in Anti Cancer Drugs Category

Merinethol Talets

Merinethol Talets

Minimum Order Quantity : 100 Boxes

Dosage Form : Tablets

Shelf Life : 24 months

Fermentation Smell : Other, Odorless

Ingredients : Other , Pancreatin, Merino Extract, Excipients

Application : Other, Used for digestive disorders and enzyme deficiencies

ARACYT 1000 MG INJection

ARACYT 1000 MG INJection

Minimum Order Quantity : 100 Boxes

Dosage Form : Injection

Shelf Life : 24 months

Fermentation Smell : Other, Odorless

Ingredients : Other , Cytarabine, excipients, sterile water for injection

Application : Other, Used intravenously for chemotherapy

Arimizole Tablet

Arimizole Tablet

Minimum Order Quantity : 100 Boxes

Dosage Form : Tablet

Shelf Life : 24 months

Fermentation Smell : Other, Odorless

Ingredients : Other , Anastrozole, Excipients

Application : Other, Oral administration as prescribed by a physician

Adriadox 50mg Injection

Adriadox 50mg Injection

Minimum Order Quantity : 100 Boxes

Dosage Form : Injection

Shelf Life : 24 months

Fermentation Smell : Other, Odorless

Ingredients : Other , Doxorubicin Hydrochloride, Excipients

Application : Other, Antineoplastic (chemotherapy), Hospital, Clinical



Back to top